BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 5055027)

  • 1. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings].
    Denegri M; Luciano L
    Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and pharmacodynamic correlations of phenobarbital (PB) and diphenylhydantoin (DPH) in the treatment of infantile epilepsy].
    De Negri M; Luciano L
    Minerva Pediatr; 1971 Dec; 23(50):2103-12. PubMed ID: 5135686
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic response relationship to phenobarbital and diphenylhydantoin serum and cerebrospinal fluid levels in epileptics.
    Volanschi D; Pintilie C; Florescu D; Tudor S
    Neurol Psychiatr (Bucur); 1975; 13(3):217-23. PubMed ID: 1188280
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and cerebrospinal fluid concentrations of phenobarbital in infants given single doses.
    Jalling B
    Dev Med Child Neurol; 1974 Dec; 16(6):781-93. PubMed ID: 4442659
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the mechanism of metabolic acidosis observed in the children treated with anticonvulsants].
    Nagai B
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):706-21. PubMed ID: 6820790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions. 3. Therapeutic implications of enzyme induction.
    Soyka LF
    Pediatrics; 1972 Sep; 50(3):489-90. PubMed ID: 5056430
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood levels of diazepam (Valium) and N-desmethyl diazepam in the epileptic child. A preliminary report.
    Viala A; Cano JP; Dravet C; Tassinari CA; Roger J
    Psychiatr Neurol Neurochir; 1971; 74(2):153-8. PubMed ID: 5149864
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primidone kinetics and analysis of its interactions with the major antiepileptic drugs].
    Ermani M; Giaretta D; Pellegrini A; Chemello R; Testa G
    Riv Neurol; 1983; 53(2):81-93. PubMed ID: 6879058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among dose, serum and CSF levels and urinary output in fenobarbital and fenitoin treatment of epileptics.
    Pintilie C; Florescu D; Tudor S; Alecu C; Macovei-Patriche M; Volanschi D
    Neurol Psychiatr (Bucur); 1975; 13(2):101-10. PubMed ID: 1188268
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical value of determination of serum concentration of antiepileptics.
    Wang L; Zuo QH; Liu SR; Wang SH
    Chin Med J (Engl); 1984 Mar; 97(3):165-70. PubMed ID: 6432478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of anticonvulsant level determination in the treatment of epilepsies].
    Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M
    Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interaction: diazoxide and diphenylhydantoin.
    Roe TF; Podosin RL; Blaskovics ME
    J Pediatr; 1975 Sep; 87(3):480-4. PubMed ID: 1165531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug compliance and therapeutic considerations in 75 black epileptic children.
    Freiman J; Buchanan N
    Cent Afr J Med; 1978 Jul; 24(7):136-40. PubMed ID: 688378
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment of epileptics with phenobarbital and diphenylhydantoin in small doses versus separate treatment with large doses of either drug. A study of the clinical effects.
    Volanschi D; Pintilie C
    Neurol Psychiatr (Bucur); 1978; 16(4):259-69. PubMed ID: 741196
    [No Abstract]   [Full Text] [Related]  

  • 17. Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat.
    Rizzo M; Morselli PL; Garattini S
    Biochem Pharmacol; 1972 Feb; 21(4):449-54. PubMed ID: 5014504
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasma diphenylhydantoin concentration in epileptic patients].
    Herishanu Y; Eylath U
    Harefuah; 1974 Sep; 87(6):251-3. PubMed ID: 4442797
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quntification of serum levels anticonvulsant].
    Hernández-Peniche J; de Astegui RB
    Prensa Med Mex; 1974; 39(11-12):478-80. PubMed ID: 4457870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.